Patients urge subsidy for cancer drugs

Google+ Pinterest LinkedIn Tumblr +

Source: The West Australian

Prescription_drugs_crpd

Melanoma patients have urged the Federal Government to add two drugs that can extend the life of advanced skin cancer patients to the nation’s subsidised medicine scheme.

Despite Australia’s reputation as the world’s skin cancer capital, Zelboraf and Yervoy, which can cost patients thousands of dollars for one treatment, have failed to be listed on the Pharmaceutical Benefits Scheme.

One patient group says cancer patients must go to extremes, such as selling their homes or fundraising, to afford the drugs….read full article

Share.

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Comments are closed.